Hematologic characterization and chromosomal localization of the novel dominantly inherited mouse hemolytic anemia, neonatal anemia (Nan)

Blood Cells, Molecules, and Diseases

Volumn 43, Issue 2, 2009, Pages 141-148

  White, Robert A ^a,b   Sokolovsky, Inna V ^a   Britt, Margaret I ^a   Nsumu, Ndona N ^a   Logsdon, Derek P ^a   McNulty, Steven G ^a   Wilmes, Leigh A ^a   Brewer, Brandon P ^a   Wirtz, Eric ^a   Joyce, Heather R ^a   Fegley, Barbara ^c   Smith, Ann ^d   Heruth, Daniel P ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Bone marrow transplantation; Erythrocyte membrane skeleton; Hemolytic anemia; Hereditary spherocytosis; Mouse model

Indexed keywords

ERYTHROCYTE BAND 4.1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 8; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; HEREDITARY SPHEROCYTOSIS; IRON DEFICIENCY ANEMIA; MOUSE; MOUSE MUTANT; NEWBORN; NEWBORN ANEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC; ANIMALS; BONE MARROW TRANSPLANTATION; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; DISEASE MODELS, ANIMAL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING;

MUS;

EID: 68049107451     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.03.009     Document Type: Article

References (48)

1. Walensky L.D., Narla M., and Lux S.E. Disorders of the red cell membrane. In: Handin R.I., Lux S.E., and Stossel T.P. (Eds). Blood: Principles and Practice of Hematology. 2nd ed. (2003), Lippincott, Williams & Wilkins Company, Philadelphia, PA 1709-1858
2. Gallagher P.G., and Jarolim P. Red blood cell membrane disorders. In: Hoffman R., Benz Jr. E.J., and Shattil S.J. (Eds). Hematology: Basic Principles and Practice. 4th ed. (2005), Elsevier, Philadelphia, PA 669-691
3. Eber S., and Lux S.E. Hereditary spherocytosis - defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin. Hematol. 41 (2004) 118-141
4. Gallagher P.G. Update on the clinical spectrum and genetics of red blood cell membrane disorders. Curr. Hematol. Rep. 3 (2004) 85-91
5. Bodine D.M., Birkenmeier C.S., and Barker J.E. Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell 37 (1984) 721-729
6. White R.A., Birkenmeier C.S., Lux S.E., and Barker J.E. Ankyrin and the hemolytic anemia mutation, nb, map to mouse Chromosome 8: presence of the nb allele is associated with a truncated erythrocyte ankyrin. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3117-3121
7. Birkenmeier C.S., Gifford E.J., and Barker J.E. Normoblastosis, a murine model for ankyrin-deficient hemolytic anemia, is caused by a hypomorphic mutation in the erythroid ankyrin gene Ank1. Hematol. J. 4 (2003) 445-449
8. Peters L.L., Shivdasani R.A., Liu S.C., Hanspal M., John K.M., Gonzalez J.M., Brugnara C., Gwynn B., Mohandas N., Alper S.L., Orkin S.H., and Lux S.E. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 86 (1996) 917-927
9. Southgate C.D., Chisti A.H., Mitchell B., Yi S.J., and Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe hemolytic anemia despite a normal membrane skeleton. Nat. Genet. 14 (1996) 227-230
10. Peters L.L., Jindel H.K., Gwynn B., Korsgren C., John K.M., Lux S.E., Mohandas N., Cohen C.M., Cho M.R., Golan D.E., and Brugnara C. Mild spherocytosis and altered red cell ion transport in protein 4.2-null mice. J. Clin. Invest. 103 (1999) 1527-1537
11. Shi Z.-T., Afzal V., Coller B., Patel D., Chasis J.A., Parra M., Lee G., Paszty C., Stevens M., Walensky L., Peters L.L., Mohandas N., Rubin E., and Conboy J.G. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Invest. 103 (1999) 331-340
12. Robledo R.F., Ciciotte S.L., Gwynn B., Sahr K.E., Gilligan D.M., Mohandas N., and Peters L.L. Targeted deletion of α-adducin results in absent β- and γ-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice. Blood 112 (2008) 4298-4307
13. Chen H., Khan A.A., Liu F., Gilligan D.M., Peters L.L., Messick J., Haschek-Hock W.M., Li X., Ostafin A.E., and Chishti A.H. Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J. Biol. Chem. 282 (2007) 4124-4135
14. Shafizadeh E., Paw B.H., Foott H., Liao E.C., Barut C.A., Cope J.J., Zon L.I., and Lin S. Characterization of zebrafish merlot/chablis as non-mammalian vertebrate models for severe congenital anemia due to protein 4.1 deficiency. Development 129 (2002) 4359-4370
15. An X., and Mohandas N. Disorders of the red cell membrane. Br. J. Haematol. 141 (2008) 367-375
16. Lyon M.F., Glenister P.H., Loutit J.F., and Peters J. Dominant hemolytic anemia, [abstract],. Mouse News Lett. 68 (1983) 68
17. White R.A., Roman S., McNulty S.G., Kohlbrecher D., Young K.N., Garg U., Wirtz E.D., Fitzgerald K.F., and Schindel B.P. Iron metabolism in the neonatal anemia (Nan) mutant mouse, [abstract]. Blood 98 (2001) 6a
18. Perrotta S., Gallagher P.G., and Mohandas N. Hereditary spherocytosis. Lancet 372 (2008) 1411-1426
19. v mice with limiting dilutions of +/+ donor marrow cells. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 7332-7335
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods (1984), Grune & Stratton, Inc., Orlando, FL
22. Whitney J.B. Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochem. Genet. 16 (1978) 667-672
23. Peters L.L., Swearingen R.A., Andersen S.G., Gwynn B., Lambert A.J., Li R., Lux S.E., and Churchill G.A. Identification of quantitative trait loci that modify the severity of hereditary spherocytosis in wan, a new mouse model of band 3 deficiency. Blood 103 (2004) 3233-3240
24. White R.A., McNulty S.G., Roman S., Garg U., Wirtz E., Kohlbrecher D., Nsumu N.N., Pinson D., Gaedigk R., Blackmore K., Copple A., Rasul S., Watanable M., and Shimizu K. Chromosomal localization, hematologic characterization, and iron metabolism of the hereditary erythroblastic anemia (hea) mutant mouse. Blood 104 (2004) 1511-1518
25. Dietrich W., Katz H., Lincoln S.E., Shin H.S., Friedman J., Dracopoli N.C., and Lander E.S. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131 (1992) 423-447
26. Zanella A., Barosi G., Berzuini A., Colombo M.B., Quaglini S., Volpes D., and Sichia G. Relative iron deficiency in hereditary spherocytosis. Am. J. Hematol. 31 (1989) 81-86
27. Sassa S., and Bernstein S.E. Studies of erythrocyte protoporphyrin in anemic mutant mice: use of a modified hematofluorometer for the detection of heterozygotes for hemolytic disease. Exp. Hematol. 6 (1978) 479-487
28. Jansen G., Koenderman L., Rijksen G., Punt K., Dekker A.W., and Staal G.E. Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am. J. Hematol. 20 (1985) 203-215
29. Lakomek M., Schroter W., De Maeyer G., and Winkler H. On the diagnosis of erythrocyte enzyme defects in the presence of high reticulocyte counts. Br. J. Haematol. 72 (1989) 445-451
30. Kapff C.T., and Jandl J.H. Hereditary spherocytosis. In: Kapff C.T., and Jandl J.H. (Eds). Blood: Atlas and Sourcebook of Hematology. 2nd ed. (1991), Little, Brown and Company, Boston, MA 42-43
31. Lyon M.F., and Glenister P.H. Position of neonatal anemia (Nan) on Chromosome 8. [abstract]. Mouse News Lett. 74 (1986) 95
32. Lyon M.F., and Glenister P.H. Neonatal anemia (Nan) on Chromosome 8. [abstract]. Mouse News Lett. 72 (1985) 107
33. Inaba M., Gupta K.C., Kuwabara M., Takahashi T., Benz E.J., and Madea Y. Deamidation of human erythrocyte protein 4.1: possible role in aging. Blood 79 (1992) 3355-3361
34. Cohen C.M., and Gascard P. Regulation and post-translational modifications of erythrocyte membrane and membrane-skeletal proteins. Semin. Hematol. 29 (1992) 244-292
35. Manno S., Takakuwa Y., and Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J. Biol. Chem. 280 (2005) 7581-7587
36. Bieker J.J. EKLF and the development of the erythroid linage. In: Ravid K., and Licht J.D. (Eds). Transcription Factors: Normal and Malignant Development of Blood Cells (2000), Wiley-Liss, New York 71-84
37. Perkins A.C., Sharpe A.H., and Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375 (1995) 318-322
38. Perkins A.C., Peterson K.R., Stamatoyannopoulos G., Witkowska H.E., and Orkin S.H. Fetal expression of a human a γ globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood 95 (2000) 1827-1833
39. Nilson D.G., Sabatino D.E., Bodine D.M., and Gallagher P.G. Major erythrocyte membrane protein genes in EKLF-deficient mice. Exp. Hematol. 34 (2006) 705-712
40. Singleton B.K., Burton N.M., Green C., Brady R.L., and Anstee D.J. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group ln(Lu) phenotype. Blood 112 (2008) 2081-2088
41. Low F.M., Hampton M.B., Peskin A.V., and Winterbourn C.C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109 (2007) 2611-2617
42. Lee T.-Y., Kim S.-U., Yu S.-L., Kim S.H., Park D.S., Moon H.-B., Dho S.H., Kwon K.-S., Kwon H.J., Han Y.-H., Jeong S., Kang S.W., Shin H.-S., Lee K.-K., Rhee S.G., and Yu D.-Y. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101 (2003) 5033-5038
43. Kawane K., Fukuyama H., Kondoh G., Takeda J., Ohsawa Y., Uchiyama Y., and Nagata S. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292 (2001) 1546-1549
44. Szebenyi G., Wigley W.C., Hall B., Didier A., Yu M., Thomas P., and Krämer H. Hook2 contributes to aggresome formation. BMC Cell Biol. 8 (2007) 19
45. Perez-Ferreiro C.M., Vernos I., and Correas I. Protein 4.1R regulates interphase microtubule organization at the centrosome. J. Cell Sci. 117 (2004) 6197-6206
46. Lumeng C., Phelps S., Crawford G.E., Walden P.D., Barald K., and Chamberlain J.S. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat. Neurosci. 2 (1999) 611-617
47. Zhi G., Ryder J.W., Huang J., Ding P., Chen Y., Zhao Y., Kamm K.E., and Stull J.T. Myosin light chain kinase and myosin phosphorylation effect frequency-dependent potentiation of skeletal muscle contraction. Proc. Nat. Acad. Sci. U. S. A. 102 (2005) 17519-17524
48. Griffiths-Jones S., Kaur Saini H., van Dongen S., and Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36 Database Issue (2008) D154-D158